|
시장보고서
상품코드
2129071
치료제 시장 : 유형별, 적응증별, 최종 사용자별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)Curative Therapeutics Market, By Type, By Indication, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
치료제 시장 규모는 2025년에 209억 830만 달러로 평가되었고, 2026-2033년 CAGR 10.6%로 성장할 전망입니다.
근치적 치료란 단순히 증상을 완화하거나 질병의 진행을 예방하는 것이 아니라, 질병의 원인을 제거할 수 있는 치료법을 말합니다. 한편, 지금까지는 증상 치료나 병리학적 과정의 저지에 주로 사용되어 왔으나, 근치적 치료는 외과적 개입, 세포·유전자 조작, 병원체 제거를 통해 환자의 건강을 회복시키는 데 도움이 됩니다. 유전성 질환, 암, 감염증, 대사성 질환 등의 질환을 고려할 때, 이러한 다양한 분야에 혁신을 가져올 큰 가능성이 있으며, 근치적 치료는 지극히 가치 있는 것이 될 것입니다. 질병의 치유나 증상 완화를 목적으로 해 온 만성 질환 치료와 달리, 병리학적 과정을 표적으로 하는 근치적 치료법은 환자를 해당 질환으로부터 확실하게 치유시킬 수 있습니다. 이러한 치료법은 지속적인 질환 해결과 환자 예후의 개선을 가져옴으로써, 헬스케어의 패러다임을 새롭게 바꾸고 있습니다.
치료제 시장 : 시장 역학
희귀질환 치료 수요에 대한 인식 제고가 시장 수요를 견인
희귀질환 및 오펀 질환에 대한 인식이 높아지면서 시장 성장에 기여하고 있습니다. 질환에 대한 이해가 깊어지고, 진단 기술이 향상되며, 미충족 의료 수요에 대한 집중이 치료제 및 질환 수정제 개발과 도입을 촉진하고 있기 때문입니다. 예를 들어, 2026년 4월 영국 정부의 ‘잉글랜드 희귀질환 행동 계획’에 따르면, 희귀질환은 평생 동안 17명 중 1명이 앓게 된다고 합니다. 영국 정부의 ‘희귀질환 행동 계획’에 따르면, 잉글랜드에서는 NHS 유전체 의료 서비스(GMS)가 유전체 검사를 실시할 수 있는 고유 질환이 7,000개 이상이며, 2025년 1월까지 유전체 기술을 통해 34만 건 이상의 검사가 제공될 전망입니다. 2025년까지 희귀질환에 대한 34만 건 이상의 유전체 검사(이 중 4만 건 이상은 전체 유전체 검사)가 실시될 전망입니다. 또한, NHS는 여전히 진단이 확정되지 않은 희귀질환 소아 및 성인 환자를 대상으로 28개의 희귀질환 공동연구 네트워크와 2개의 시범 센터를 설립했습니다. 이러한 노력을 통해 희귀질환에 대한 인식, 진단 및 혁신적인 치료법에 대한 접근성이 강화되고 있습니다.
치료제 시장 : 시장 세분화 분석
세계 치료제 시장은 유형, 적응증, 최종 사용자 및 지역에 따라 세분화되어 있습니다.
질환 수정 치료제 부문은 질환의 병태를 수정하고 지속적인 치료를 가능하게 하는 능력 덕분에 큰 점유율을 차지하고 있습니다. 예를 들어, 2025년 12월 기준 미국 국립생물공학정보센터(NCBI)에 따르면, 질병 수정 항류마티스제(DMARD)는 기존 DMARD, 생물학적 제제, 표적 합성 DMARD의 3가지 유형으로 분류됩니다. 미국 국립생물공학정보센터(NCBI)에 따르면, 인플릭시맙, 아달리무맙, 에타넬셉트, 릿룩시맙, 아바타셉트, 토시리주맙을 포함한 6유형의 생물학적 DMARD가 존재합니다. 또한, 생물학적 DMARD는 비경구 투여(정맥 내 및 피하)로 이루어진다는 점에 유의해야 합니다. 이를 통해 질환 수정 요법의 활용 확대와 더불어, 이러한 질환에 대한 치료 선택지의 개선이 기대됩니다.
치료제 시장 : 지역별 분석
북미 치료제 시장은 높은 질환 유병률, 잘 정비된 의료 제도, 연구 개발 활동, 그리고 발전된 제약·생명공학 산업을 배경으로 매출 점유율 1위를 유지할 것으로 예측됩니다. 예를 들어, 2026년 4월 기준 미국 노동통계국(Gov)의 데이터에 따르면, 인도는 미국으로의 의약품 및 의료 제품 제조 분야에서 최대 수출국이며, 수출액은 314억 달러에 달할 전망입니다. 그 뒤를 이어 2위는 푸에르토리코(167억 달러), 3위는 노스캐롤라이나주(143억 달러), 캘리포니아주(95억 달러), 일리노이주(86억 달러), 펜실베이니아주(77억 달러) 순입니다. 이러한 수출액은 미국의 주요 주와 영토에 확고한 의약품 제조거점이 존재함을 보여줍니다.
아시아태평양에서는 인구 증가, 질병 부담, 의료비 증가 및 의료 환경의 변화를 배경으로 현저한 성장이 예상됩니다. 2026년 6월 기준 인도 정부의 발표에 따르면, 인도 국내에서 운영 중인 186,000곳의 ‘아유슈만 아로기야 만디르’를 통한 공중보건 서비스 제공을 통해 공중보건 인프라가 지속적으로 확충될 전망입니다. 여기에는 134,000곳의 서브 헬스 센터, 24,483곳의 1차 보건 센터, 5,474곳의 도시 1차 보건 센터, 12,259곳의 AYUSH 센터,그리고 9,758곳의 도시 지역 건강·웰니스 센터로 구성되어 있습니다. 또한 PM-ABHIM에는 총 6,418억 루피의 예산이 배정되어 있으며, 23,224곳의 농촌 보건·웰니스 센터, 13,736곳의 도시 보건·웰니스 센터, 3,389곳의 블록 수준 공중보건 단위, 744곳의 통합 공중보건 연구소, 그리고 631곳의 중환자실에 서비스를 제공합니다. 이러한 진전을 통해 의료 서비스 접근성이 강화되고, 의료 서비스에 대한 수요가 지속적으로 증가할 것으로 기대됩니다.
목차
제1장 치료제 시장 개요
제2장 주요 요약
제3장 치료제 주요 시장 동향
제4장 치료제 산업 분석
제5장 치료제 시장 : 높아지는 지정학적 긴장의 영향
제6장 치료제 시장 구도
제7장 치료제 시장 : 유형별
제8장 치료제 시장 : 적응증별
제9장 치료제 시장 : 최종 사용자별
제10장 치료제 시장 : 지역별
제11장 주요 벤더 분석 : 치료제 산업
제12장 AnalystView 전방위 전망
AJY 26.09.17Curative Therapeutics market size was valued at US$ 20,908.3 Million in 2025, expanding at a CAGR of 10.6% from 2026 to 2033.
Curative therapeutics are basically the treatment procedures which have the ability to get rid of the cause of a disease, as opposed to just treating symptoms and preventing disease progression. On the other hand, they have been used to treat symptoms or stop the pathological process, but curative therapies can help bring back the health of patients through surgical intervention, cellular and genetic manipulation and getting rid of the pathogenic agents, and this could be highly valuable when considering diseases like genetic disorders, cancer, infections and metabolic diseases, as there is a lot of transformative power in all these various fields. Unlike chronic disease treatments which have been aimed at curing or relieving the symptoms of a disease, curative therapies that target the pathological process would definitely cure a patient of such a disease. These therapies are reshaping healthcare by offering lasting disease resolution and improved patient outcomes.
Curative Therapeutics Market- Market Dynamics
Growing Recognition of Rare Disease Treatment Needs to Propel Market Demand
Growing recognition of rare and orphan diseases is helping to grow the market, as more awareness about diseases, better diagnosis, and concentration on unmet medical needs are prompting the development and adoption of curative and disease-modifying drugs. For instance, in April 2026, according to the UK government's England Rare Diseases Action Plan, rare diseases collectively affect 1 of 17 people during their lifetime. The UK Govt. Rare Diseases Action Plan stated that there are more than 7,000 unique conditions for which the NHS Genomic Medicine Service (GMS) can conduct genomic tests in England, while more than 340,000 will be provided through genome technologies by January 2025. It will have performed more than 340,000 genomic tests for rare diseases, including more than 40,000 whole-genome equivalents, by 2025. In addition, the NHS had established 28 Rare Disease Collaborative Networks and 2 pilot centers for children and adults with rare diseases that are still undiagnosed. These initiatives are strengthening rare disease recognition, diagnosis, and access to innovative therapeutic solutions.
Curative Therapeutics Market- Segmentation Analysis:
The Global Curative Therapeutics market is segmented on the basis of Type, Indication, End User, and Region.
The biology-modifying drugs segment holds a significant share because of the ability to modify disease pathogenesis and deliver continuous treatment. For instance, in December 2025, according to the National Center for Biotechnology Information (NCBI), Disease-Modifying Antirheumatic Drugs (DMARDs) are grouped into 3 types, which are traditional DMARDs, biologics, and targeted synthetic DMARDs. The National Center for Biotechnology Information (NCBI) states that there are 6 biologic DMARDs, including infliximab, adalimumab, etanercept, rituximab, abatacept, and tocilizumab. It should be noted that biologic DMARDs are administered in a parenteral manner (intravenously and subcutaneously). This provides opportunities for improved treatment options for these diseases along with increasing disease-modifying therapy usage.
Curative Therapeutics Market- Geographical Insights
The North American Curative Therapeutics market is expected to hold a leading revenue share due to the prevalence of diseases, the well-developed healthcare system, research and development activities, and the developed pharmaceutical and biotechnology industries. For example, in April 2026, according to the Bureau of Labor Statistics (Gov), India is the leading exporter of pharmaceutical and medicine manufacturing in the U.S., exporting a value of USD 31,400 million, followed by Puerto Rico in second place with a value of USD 16,700 million; North Carolina (USD 14,300 million); California (USD 9,500 million); Illinois (USD 8,600 million); and Pennsylvania (USD 7,700 million). These export values highlight the well-established pharmaceutical manufacturing base across major U.S. states and territories.
The Asia Pacific region is expected to witness significant growth, backed by population growth, burden of disease, increased healthcare expenditures, and changing nature of the healthcare environment. June 2026, according to the Government of India, indicates that there will be continuous growth in the public health infrastructure through public health services provision in 186,000 Ayushman Arogya Mandirs functioning in India, which comprise 134,000 sub-health centres, 24,483 primary health centres, 5,474 urban primary health centres, 12,259 AYUSH centres, and 9,758 urban health and wellness centres as of June 5, 2026. Additionally, the PM-ABHIM has been allotted a total budget of Rs 64,180 crores and provides services to 23,224 rural health and wellness centres, 13,736 urban health and wellness centres, 3,389 block-level public health units, 744 integrated public health laboratories, and 631 critical care hospital blocks. These developments are expected to strengthen healthcare access and drive continued demand for healthcare services.
Curative Therapeutics Market- Competitive Landscape:
The Curative Therapeutics market is populated by firms like Gilead Sciences, Inc., Pfizer Inc., Amgen Inc., Novartis Pharmaceuticals Corporation, and Sarepta Therapeutics, Inc. The leading firms in the curative therapeutics industry are making efforts in trying to develop new drugs and treatments for the core diseases. Research and development by these firms using different strategies lead to bringing change in the competitive environment in the curative therapeutics industry. In February 2026, Gilead Sciences concluded its deal for the acquisition of Arcellx for about USD 7.8 billion in an effort to get the BCMA-directed CAR-T cell product candidate named Anto-cel used to treat multiple myeloma. These strategic initiatives strengthen innovation, expand treatment capabilities, and intensify competition across the curative therapeutics market.
Recent Developments:
In February 2026, Sarepta Therapeutics made an announcement about the market launch of ELEVIDYS (delandistrogene moxeparvovec) in Japan, in partnership with Chugai Pharmaceutical, thereby making their single-dose gene therapy .
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CURATIVE THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Sarepta Therapeutics, Inc.
- Vertex Pharmaceuticals Incorporated
- Alnylam Pharmaceuticals, Inc.
- Amgen Inc.
- Beam Therapeutics Inc.
- CRISPR Therapeutics AG
- Intellia Therapeutics, Inc.
- Cartesian Therapeutics, Inc.
- Curative Biotechnology, Inc.
- CureAge Therapeutics
- Jnana Therapeutics, Inc.
- Kymera Therapeutics, Inc.
- MiNA Therapeutics Ltd.
- Seagen Inc.
- Cellectis S.A.
- Editas Medicine, Inc.
- Sangamo Therapeutics, Inc.
- Precision BioSciences, Inc.
- Others
GLOBAL CURATIVE THERAPEUTICS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Cell Therapies
- Gene Therapies
- Biology Modifying Drugs
GLOBAL CURATIVE THERAPEUTICS MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033
- Hepatitis C
- Rare Diseases
- Neurodegenerative Diseases
- Musculoskeletal Disorders
- Cancer
- Others
GLOBAL CURATIVE THERAPEUTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Academic & Research Institutions
- Pharmaceutical Companies
- Others
GLOBAL CURATIVE THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. Curative Therapeutics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Curative Therapeutics Market Snippet by Type
- 2.1.2. Curative Therapeutics Market Snippet by Indication
- 2.1.3. Curative Therapeutics Market Snippet by End User
- 2.1.4. Curative Therapeutics Market Snippet by Country
- 2.1.5. Curative Therapeutics Market Snippet by Region
- 2.2. Competitive Insights
3. Curative Therapeutics Key Market Trends
- 3.1. Curative Therapeutics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Curative Therapeutics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Curative Therapeutics Market Opportunities
- 3.4. Curative Therapeutics Market Future Trends
4. Curative Therapeutics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Curative Therapeutics Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Curative Therapeutics Market Landscape
- 6.1. Curative Therapeutics Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Curative Therapeutics Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Cell Therapies
- 7.1.3. Gene Therapies
- 7.1.4. Biology Modifying Drugs
8. Curative Therapeutics Market - By Indication
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
- 8.1.2. Hepatitis C
- 8.1.3. Rare Diseases
- 8.1.4. Neurodegenerative Diseases
- 8.1.5. Musculoskeletal Disorders
- 8.1.6. Cancer
- 8.1.7. Others
9. Curative Therapeutics Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 9.1.2. Academic & Research Institutions
- 9.1.3. Pharmaceutical Companies
- 9.1.4. Others
10. Curative Therapeutics Market - By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Curative Therapeutics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Curative Therapeutics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.8. UK
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.8.4. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.9. France
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.9.4. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.10. Italy
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.10.4. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.11. Spain
- 10.3.11.1. Overview
- 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.11.4. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.12. The Netherlands
- 10.3.12.1. Overview
- 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.12.4. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Overview
- 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.14. Russia
- 10.3.14.1. Overview
- 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.14.4. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.15. Poland
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.15.4. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.16. Denmark
- 10.3.16.1. Overview
- 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.16.4. Denmark Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.17. Rest of Europe
- 10.3.17.1. Overview
- 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.17.4. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Curative Therapeutics Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.7. China
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.7.4. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.8. India
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.8.4. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.12. Indonesia
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.12.4. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.13. Thailand
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.13.4. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.15. Taiwan
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.15.4. Taiwan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.16. Vietnam
- 10.4.16.1. Overview
- 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.16.4. Vietnam Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.17. Rest of APAC
- 10.4.17.1. Overview
- 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.17.4. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Curative Therapeutics Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Curative Therapeutics Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.8. UAE
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.8.4. UAE Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.13. Iran
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.13.4. Iran Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.14. Qatar
- 10.6.14.1. Overview
- 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.14.4. Qatar Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.15. Rest of MEA
- 10.6.15.1. Overview
- 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.15.4. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Curative Therapeutics Industry
- 11.1. Competitive Benchmarking
- 11.1.1. Competitive Dashboard
- 11.1.2. Competitive Positioning
- 11.2. Company Profiles
- 11.2.1. Sarepta Therapeutics, Inc.
- 11.2.2. Vertex Pharmaceuticals Incorporated
- 11.2.3. Alnylam Pharmaceuticals, Inc.
- 11.2.4. Amgen Inc.
- 11.2.5. Beam Therapeutics Inc.
- 11.2.6. CRISPR Therapeutics AG
- 11.2.7. Intellia Therapeutics, Inc.
- 11.2.8. Cartesian Therapeutics, Inc.
- 11.2.9. Curative Biotechnology, Inc.
- 11.2.10. CureAge Therapeutics
- 11.2.11. Jnana Therapeutics, Inc.
- 11.2.12. Kymera Therapeutics, Inc.
- 11.2.13. MiNA Therapeutics Ltd.
- 11.2.14. Seagen Inc.
- 11.2.15. Cellectis S.A.
- 11.2.16. Editas Medicine, Inc.
- 11.2.17. Sangamo Therapeutics, Inc.
- 11.2.18. Precision BioSciences, Inc.
- 11.2.19. Others
12. 360 Degree AnalystView
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
